Stauderman Kenneth A. 4
4 · CalciMedica, Inc. · Filed Apr 25, 2025
Insider Transaction Report
Form 4
Stauderman Kenneth A.
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-04-23+125,000→ 125,000 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Beginning March 26, 2025, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period.